The trademark EPVAX was filed by ModernaTX, Inc., a U.S. corporation (the "Applicant"). The application was published for oppositions on June 8, 2022, and received one opposition filed on June 27, 2022 by Sanofi Pasteur Europe on Likelihood of confusion. the opponent was represented by CASALONGA ALICANTE, S.L. and proceedings were handled in English, and the oppositon was dismissed by the Euorpean Union Intellectual Property Office with decision issued June 27, 2022
The application was filed in English, and English was also language of all opposition proceedings (German was selected as the second language).
Appointment and Replacement of representative of the trademark registration was recorded on January 15, 2024. Appointment and Replacement of representative of the trademark registration was recorded on May 13, 2024. Change of name and address of the trademark registration was recorded on May 14, 2024.
The Opposition with reference B 003173714 was rejected according to Article 8(1)(b) EUTMR with decision issued on October 22, 2023 by the EUIPO.